SLC4A1 and metabolic dysfunction-associated steatohepatitis: None of the pathways overlapping between DIAMOND and advanced NASH patients are involved in fibrotic processes, whereas WD1 and WD2 showed 3/7 and 12/17 of overlapping pathways, respectively.